Abstract：【Objective】To investigate the clinical efficacy of omeprazole, octreotide and thrombin in the treatment of liver cirrhosis complicated with esophageal and gastric variceal bleeding. 【Methods】A total of 88 patients with liver cirrhosis complicated with esophageal and gastric variceal bleeding treated in our hospital from April 2018 to April 2021 were prospectively selected. They were randomly divided into observation group and control group, with 44 cases in each group. The control group was treated with omeprazole and octreotide, and the observation group was treated with thrombin on the basis of the control group. The therapeutic effects of the two groups were compared, and the hemostasis time, blood transfusion volume, symptom relief time, hospital stay and adverse reactions were observed.【Results】The total effective rate of the control group was 77.27% (34/44), which was significantly lower than 93.18% (41/44) in the observation group (χ2=4.423,P=0.035 < 0.05). The hemostasis time, symptom improvement time and hospitalization time of the observation group were shorter than those of the control group, and the amount of blood transfusion was lower than that of the control group (P<0.05). The incidence of adverse reactions in the control group was 9.09% (4/44), which was higher than 4.55% (2/44) in the observation group, but the difference was not statistically significant (χ2=4.062, P=0.443>0.05). 【Conclusion】The combination of omeprazole, octreotide and thrombin in the treatment of liver cirrhosis complicated with esophageal and gastric variceal bleeding has good clinical efficacy, good hemostatic effect, good safety and good prognosis.
彭雄群, 易艳容, 郭海燕. 奥美拉唑、奥曲肽和凝血酶联合治疗肝硬化并发食管胃底静脉曲张破裂出血患者的临床疗效[J]. 医学临床研究, 2022, 39(3): 363-365.
PENG Xiong-qun, YI Yan-rong, GUO Hai-yan. Clinical Efficacy of Omeprazole, Octreotide and Thrombin in the Treatment of Liver Cirrhosis Complicated with Esophageal and Gastric Variceal Bleeding. JOURNAL OF CLINICAL RESEARCH, 2022, 39(3): 363-365.
2022, Vol. 39 
